RXRX
#2093
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.3 0 USD
-0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-7.30%
Monthly Change
0.00%
6 month change
-31.96%
Year Change
-37.85%
Previous Close
3.5 6
Open
3.3 0
Low
3.3 0
High
3.3 0
Volume
93
Financials
- Market Capitalization 1.75 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.84
Price to sales ratio
24.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2069 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.04 USD | -4.49% | -4.94% | -1.94% | +113.76% | 1.80 B USD | ||
| 2088 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 27.88 USD | -2.99% | +5.25% | +35.27% | +5.37% | 1.76 B USD | ||
| 2112 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.86 USD | +0.56% | -0.78% | +6.88% | +250.88% | 1.69 B USD | ||
| 2123 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 36.57 USD | -6.99% | +4.34% | +31.12% | +92.47% | 1.66 B USD |
Frequently asked questions about Recursion Pharmaceuticals, Inc. - Class A Common Stock
What is the Recursion Pharmaceuticals, Inc. - Class A Common Stock stock price today?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) is 3.3. Over the past 24 hours, the stock has changed by -7.30%. Follow the RXRX chart for real-time price dynamics.
What is the stock ticker of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades under the ticker RXRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock stock going up?
RXRX has changed by -16.46% over the last week, 0.00% over the last month, and -37.85% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Recursion Pharmaceuticals, Inc. - Class A Common Stock net income for the last quarter?
Recursion Pharmaceuticals, Inc. - Class A Common Stock reported net income of -117.5 M for the last quarter. The previous quarter showed -108.12 M, which means net income changed by -8.68%.
How many employees does Recursion Pharmaceuticals, Inc. - Class A Common Stock have?
As of the latest available data, Recursion Pharmaceuticals, Inc. - Class A Common Stock has 600 employees. Workforce size can provide additional context about the company's scale and operations.
What is Recursion Pharmaceuticals, Inc. - Class A Common Stock EBITDA?
Recursion Pharmaceuticals, Inc. - Class A Common Stock EBITDA is -108.83 M, and its EBITDA margin is -1 681.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Recursion Pharmaceuticals, Inc. - Class A Common Stock stock?
You can buy Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Recursion Pharmaceuticals, Inc. - Class A Common Stock stock?
Investing in Recursion Pharmaceuticals, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RXRX chart and related analysis on metatrader.com as part of your research.